| Product Code: ETC8547068 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Prophylactic Vaccines Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Prophylactic Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Prophylactic Vaccines Market - Industry Life Cycle |
3.4 Netherlands Prophylactic Vaccines Market - Porter's Five Forces |
3.5 Netherlands Prophylactic Vaccines Market Revenues & Volume Share, By Vaccine Type, 2021 & 2031F |
3.6 Netherlands Prophylactic Vaccines Market Revenues & Volume Share, By Disease, 2021 & 2031F |
3.7 Netherlands Prophylactic Vaccines Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 Netherlands Prophylactic Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.9 Netherlands Prophylactic Vaccines Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Netherlands Prophylactic Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing diseases |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Technological advancements in vaccine development and administration |
4.3 Market Restraints |
4.3.1 Vaccine hesitancy and misinformation |
4.3.2 High costs associated with vaccine research and development |
4.3.3 Regulatory challenges in getting approvals for new vaccines |
5 Netherlands Prophylactic Vaccines Market Trends |
6 Netherlands Prophylactic Vaccines Market, By Types |
6.1 Netherlands Prophylactic Vaccines Market, By Vaccine Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Vaccine Type, 2021- 2031F |
6.1.3 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Live/Attenuated Vaccines, 2021- 2031F |
6.1.4 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021- 2031F |
6.1.5 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Subunit Vaccines, 2021- 2031F |
6.1.6 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Toxoid Vaccines, 2021- 2031F |
6.1.7 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Conjugate Vaccines, 2021- 2031F |
6.1.8 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Recombinant Vector Vaccines, 2021- 2031F |
6.2 Netherlands Prophylactic Vaccines Market, By Disease |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Pneumococcal Disease, 2021- 2031F |
6.2.3 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Poliovirus, 2021- 2031F |
6.2.4 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.2.5 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Influenza, 2021- 2031F |
6.2.6 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Measles, 2021- 2031F |
6.2.7 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Mumps, 2021- 2031F |
6.2.8 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.2.9 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Varicella, 2021- 2031F |
6.3 Netherlands Prophylactic Vaccines Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Intramuscular Route, 2021- 2031F |
6.3.3 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Subcutaneous Route, 2021- 2031F |
6.3.4 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3.5 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Intravenous Injection, 2021- 2031F |
6.3.6 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Administration Routes, 2021- 2031F |
6.4 Netherlands Prophylactic Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Retail Pharmacy and Online Pharmacy, 2021- 2031F |
6.5 Netherlands Prophylactic Vaccines Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Homecare, 2021- 2031F |
6.5.4 Netherlands Prophylactic Vaccines Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
7 Netherlands Prophylactic Vaccines Market Import-Export Trade Statistics |
7.1 Netherlands Prophylactic Vaccines Market Export to Major Countries |
7.2 Netherlands Prophylactic Vaccines Market Imports from Major Countries |
8 Netherlands Prophylactic Vaccines Market Key Performance Indicators |
8.1 Vaccination coverage rate among target population groups |
8.2 Number of new prophylactic vaccines introduced to the market |
8.3 Research and development investment in vaccine innovation |
9 Netherlands Prophylactic Vaccines Market - Opportunity Assessment |
9.1 Netherlands Prophylactic Vaccines Market Opportunity Assessment, By Vaccine Type, 2021 & 2031F |
9.2 Netherlands Prophylactic Vaccines Market Opportunity Assessment, By Disease, 2021 & 2031F |
9.3 Netherlands Prophylactic Vaccines Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 Netherlands Prophylactic Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.5 Netherlands Prophylactic Vaccines Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Netherlands Prophylactic Vaccines Market - Competitive Landscape |
10.1 Netherlands Prophylactic Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Prophylactic Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here